An adoptive cell therapy using Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)‐overexpressing macrophages effectively mitigates the transition from acute kidney injury (AKI) to chronic kidney disease (CKD) in UIRI animals. This evidence concerns the gene TREM2 and chronic kidney disease.